Abstract
The emergence of resistant microorganisms to a large number of clinically approved antimicrobials has been increasingly used, which limits the options for the treatment of bacterial infections. As a strategy, drugs with high antimicrobial activities are in evidence. Stands out a class of antimicrobial, the cephalosporins, having as fourth generation cefepime a semi-synthetic product which…